NDC 78206-162 – Renflexis

Infliximab 100 mg/1 · Injection, Powder, Lyophilized, For Solution · Intravenous

Human Prescription Drug

Product NDC78206-162

Product details

Brand name
Renflexis
Generic name
Infliximab
Labeler
Organon LLC
Dosage form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Marketing category
BLA · BLA761054
Marketed since
April 21, 2017
Listing expires
December 31, 2027
Pharmacologic class
Tumor Necrosis Factor Blocker

Active ingredients

Uses, dosage, side effects and warnings for Renflexis →

Package NDC codes (1)

Package NDCDescriptionSince
78206-162-011 VIAL in 1 CARTON (78206-162-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (78206-162-99)Jun 1, 2021